Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis [Phase 4]
A Phase 4 trial comparing aripiprazole and risperidone for treating first-episode psychosis in schizophrenia; results have been posted.
-
CLINICAL_TRIALS research · 2016-08-30Clinical Trial Update: Emotion Endophenotypes in Schizophrenia [NA]
This entry reports a schizophrenia trial examining emotion endophenotypes, sponsored by Assistance Publique Hopitaux De Marseille, with the …
-
FDA approval · 2016-08-29FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC. This action confirms approval …
-
FDA approval · 2016-08-29FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA label_change · 2016-08-29FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA supplemental application for chlorpromazine hydrochloride filed by Upsher-Smith Laboratories, LLC, related to labeling changes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia [Phase 2]
This document notes the completion of a Phase 2 trial evaluating varenicline on cognitive function in cigarette smokers with schizophrenia o…
-
CLINICAL_TRIALS research · 2016-08-26Clinical Trial Update: Visual Exploration and Attention: Studies in Patients With Schizophrenia and Autism Spectrum Disorders
A ClinicalTrials.gov entry describes studies on visual exploration and attention in patients with schizophrenia and autism spectrum disorder…
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Enhancing Social Interaction With an AlterEgo Artificial Agent [NA]
Clinical trial update describing the use of an AlterEgo artificial agent to enhance social interaction in schizophrenia patients.
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia [Phase 2]
Pfizer's Phase 2 outpatient trial evaluating PF-02545920 as an adjunctive treatment for schizophrenia was terminated, with results posted in…
-
FDA approval · 2016-08-18FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approves a supplemental application for ABILIFY MAINTENA (aripiprazole) from Otsuka America Pharmaceutical, Inc.
-
FDA approval · 2016-08-18FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
FDA approved a supplemental application for ARISTADA (aripiprazole lauroxil) from Alkermes, Inc.
-
FDA approval · 2016-08-18FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for aripiprazole from Apotex Corp., authorizing a generic version of the drug. This action represent…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Non-invasive Brain Stimulation for Auditory Verbal Hallucinations in Schizophrenia [NA]
A completed clinical trial evaluated non-invasive brain stimulation as a treatment for auditory verbal hallucinations in schizophrenia.
-
CLINICAL_TRIALS research · 2016-08-16Clinical Trial Update: Response Shift and Quality of Life in Patients Suffering From Schizophrenia and Their Caregivers [NA]
This document reports a clinical trial update examining response shift and quality of life in people with schizophrenia and their caregivers…
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Early Detection and Intervention for the Prevention of Psychosis [NA]
Completed clinical trial from MaineHealth studied early detection and intervention to prevent psychosis and posted results in August 2016 ac…
-
CLINICAL_TRIALS withdrawal · 2016-08-15Clinical Trial Update: Sodium Butyrate For Improving Cognitive Function In Schizophrenia [Phase 2, Phase 3]
Phase 2/Phase 3 trial of sodium butyrate for improving cognitive function in schizophrenia has been withdrawn.
-
CLINICAL_TRIALS research · 2016-08-05Clinical Trial Update: A Study of an Cognitive Behaviour Therapy for Internalised Stigma Intervention for Inpatients With Psychosis [NA]
This document provides an update on a clinical trial evaluating a cognitive behaviour therapy intervention to address internalised stigma in…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: Motivational Interviewing to Improve Work Outcomes in Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating motivational interviewing to improve work outcomes in schizophrenia and schizoaffective disorder. The stud…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients [NA]
This completed placebo-controlled trial evaluated the physiological effects of L-methylfolate in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case Series [NA]
This clinical trial update reports on a case-series evaluation of the Self Directed Positive Parenting Program (Triple P) for psychosis in s…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Evaluation of Mirtazapine and Folic Acid for Schizophrenia: [Phase 4]
A Phase 4 trial evaluating the combination of mirtazapine and folic acid for schizophrenia has completed.
-
CLINICAL_TRIALS withdrawal · 2016-08-01Clinical Trial Update: Comparison of the Effectiveness of Brexpiprazole With That of Risperidone [Phase 3]
Phase 3 trial comparing brexpiprazole with risperidone for schizophrenia has been withdrawn.
-
CLINICAL_TRIALS research · 2016-08-01Clinical Trial Update: Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients [NA]
Update on a clinical trial evaluating a two-stage integrated treatment for inpatients with schizophrenia in China; however, the current phas…
-
CLINICAL_TRIALS research · 2016-07-28Clinical Trial Update: Prevalence of and Factors Associated With Metabolic Syndrome in Schizophrenia
This completed study investigates how prevalent metabolic syndrome is among individuals with schizophrenia and examines factors associated w…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Reliability and Validity of Thai Calgary Depression Scale of Schizophrenia (CDSS)
A completed clinical trial evaluating the reliability and validity of the Thai version of the Calgary Depression Scale for Schizophrenia (CD…